Werner Aberer

Q: What Schools Are Affiliated With Werner Aberer

Werner Aberer is affiliated with the following schools: University of Graz, University of Zurich, Medical University of Graz, University of Innsbruck, University of Ulm

Werner Aberer's AcademicInfluence.com Rankings

Werner Aberer

Computer Science

#8331

World Rank

#8758

Historical Rank

Database

#5352

World Rank

#5554

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Werner Aberer's Degrees

PhD Computer Science University of Zurich

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2026

Why Is Werner Aberer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Werner Aberer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. (2014) (1106)
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria (2018) (1014)
Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations (2003) (780)
Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper (2013) (689)
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group (2014) (551)
Diagnosis of immediate allergic reactions to beta‐lactam antibiotics (2003) (525)
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. (2010) (496)
Ultraviolet light depletes surface markers of Langerhans cells. (1981) (455)
Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. (2009) (365)
National rates and regional differences in sensitization to allergens of the standard series (1997) (360)
The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update (2015) (348)
Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. (2011) (306)
General considerations on rapid desensitization for drug hypersensitivity – a consensus statement (2010) (282)
Diagnosis of nonimmediate reactions to β‐lactam antibiotics (2004) (266)
Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light. (1981) (242)
Skin testing in patients with hypersensitivity reactions to iodinated contrast media – a European multicenter study (2009) (228)
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. (2012) (224)
Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. (2005) (205)
Birch pollen-related food allergy: clinical aspects and the role of allergen-specific IgE and IgG4 antibodies. (2011) (197)
Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. (1988) (192)
Diagnostic Tests Based on Human Basophils: More Potentials and Perspectives than Pitfalls (2008) (187)
Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus (2015) (186)
Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. (2010) (185)
MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation (2015) (178)
Desensitization in delayed drug hypersensitivity reactions – an EAACI position paper of the Drug Allergy Interest Group (2013) (176)
The European baseline series in 10 European Countries, 2005/2006 – Results of the European Surveillance System on Contact Allergies (ESSCA) (2009) (172)
Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. (2014) (162)
International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency (2016) (138)
Patch testing with contact allergens (2008) (137)
Guideline for the diagnosis of drug hypersensitivity reactions (2015) (136)
Current patch test results with the European baseline series and extensions to it from the ‘European Surveillance System on Contact Allergy’ network, 2007–2008 (2012) (132)
International consensus on hereditary and acquired angioedema. (2012) (131)
Reproducibility of patch tests. A multicenter study of synchronous left-versus right-sided patch tests by the German Contact Dermatitis Research Group. (1994) (130)
The European standard series in 9 European countries, 2002/2003 – First results of the European Surveillance System on Contact Allergies (2005) (129)
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle (2016) (124)
Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment (2013) (124)
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity (2018) (123)
Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. (1987) (123)
Management of chronic hand eczema (2007) (121)
Prednisolone vs. ciclosporin for severe adult eczema. An investigator‐initiated double‐blind placebo‐controlled multicentre trial (2010) (118)
The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study (2004) (114)
The European Surveillance System of Contact Allergies (ESSCA): results of patch testing the standard series, 2004 (2008) (113)
Recombinant allergen-based IgE testing to distinguish bee and wasp allergy. (2010) (112)
Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. (2002) (106)
Patch test results with the metalworking fluid series of the German Contact Dermatitis Research Group (DKG) (2004) (104)
Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study (2013) (102)
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update (2022) (102)
M2, A novel myelomonocytic cell surface antigen and its distribution on leukemic cells (1984) (102)
Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. II. Technical issues. (2008) (97)
Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (96)
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement (2016) (95)
[Performing patch testing with contact allergens]. (2008) (95)
Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region. (1987) (94)
Problems and challenges of predatory journals (2018) (94)
The seamy side of natural medicines: contact sensitization to arnica (Arnica montana L.) and marigold (Calendula officinalis L.) (2001) (92)
Identification of plectin in different human cell types and immunolocalization at epithelial basal cell surface membranes. (1984) (92)
The basophil activation test in the diagnosis of allergy: technical issues and critical factors (2009) (91)
Vaccination despite thimerosal sensitivity (1991) (89)
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (2019) (87)
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence (2018) (87)
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. (2014) (87)
Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare. (2014) (87)
Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper (2015) (86)
Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen. (2011) (85)
Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies (2012) (85)
Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells. (1986) (85)
Palladium in dental alloys – the dermatologists’responsibility to warn? (1993) (84)
Diagnosis of immediate-type beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study. (2009) (81)
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma (2019) (80)
Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America (2017) (78)
Homozygous gene deletions of the glutathione S-transferases M1 and T1 are associated with thimerosal sensitization (2000) (78)
CD203c‐based basophil activation test in allergy diagnosis: Characteristics and differences to CD63 upregulation (2010) (77)
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema (2018) (76)
Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergy. (2011) (76)
Langerhans cells as stimulator cells in the murine primary epidermal cell-lymphocyte reaction: alteration by UV-B irradiation. (1982) (73)
S2k guideline on diagnosis and treatment of atopic dermatitis – short version (2016) (73)
Inconsistent Results of Diagnostic Tools Hamper the Differentiation between Bee and Vespid Venom Allergy (2011) (72)
Evidence‐based (S3) guideline on topical corticosteroids in pregnancy (2011) (70)
Patch testing in children – recommendations of the German Contact Dermatitis Research Group (DKG) (2007) (70)
Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy (2007) (68)
Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32 (2018) (68)
Chemical substances and contact allergy--244 substances ranked according to allergenic potency. (2003) (68)
Controversies in Drug Allergy: Radiographic Contrast Media. (2019) (67)
New Onset of Dermatomyositis/Polymyositis during Anti-TNF-α Therapies: A Systematic Literature Review (2014) (66)
A characterization of the nucleotide uptake of chromaffin granules of bovine adrenal medulla. (1978) (66)
Guideline contact dermatitis (2014) (66)
S2k guideline on diagnosis and treatment of atopic dermatitis — short version (2016) (64)
Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting. (2016) (64)
Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus (2015) (62)
Immediate pigment darkening phenomenon. A reevaluation of its mechanisms. (1986) (61)
Histamine intolerance: lack of reproducibility of single symptoms by oral provocation with histamine: A randomised, double-blind, placebo-controlled cross-over study (2010) (60)
Provocation tests in drug hypersensitivity. (2009) (59)
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project (2009) (57)
Clinical Effectiveness of Hymenoptera Venom Immunotherapy: A Prospective Observational Multicenter Study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity (2013) (56)
Efficacy and Safety of Imiquimod Versus Podophyllotoxin in the Treatment of Anogenital Warts (2011) (55)
Diclofenac Hypersensitivity: Antibody Responses to the Parent Drug and Relevant Metabolites (2010) (54)
Anaphylactic shock following peritumoral injection of patent blue in sentinel lymph node biopsy procedure. (2000) (54)
Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (2016) (52)
Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema. (2016) (50)
Exposure by desialylation of myeloid antigens on acute lymphoblastic leukemia cells. (1984) (50)
Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. (2009) (50)
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2016) (49)
Drug allergy passport and other documentation for patients with drug hypersensitivity – An ENDA/EAACI Drug Allergy Interest Group Position Paper (2016) (49)
Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL. (2016) (49)
CHARACTERIZATION AND TOPOGRAPHY OF THE GLYCOPROTEINS OF ADRENAL CHROMAFFIN GRANULES (1979) (48)
Multiple sensitivities to metals (1996) (48)
Neurodermitis S2‐Leitlinie (2009) (48)
Time course of serum inhibitory activity for facilitated allergen–IgE binding during bee venom immunotherapy in children (2009) (48)
Open‐label, multicenter study of self‐administered icatibant for attacks of hereditary angioedema (2014) (46)
Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in Europe. (2012) (46)
Effect of glucocorticosteroids on epidermal cell-induced immune responses. (1984) (46)
Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE. (2013) (46)
Genotype and phenotype of N‐acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy (1998) (44)
Quantitative patch and repeated open application testing in hydroxyisohexyl 3‐cyclohexene carboxaldehyde sensitive‐patients (2009) (43)
Etiologic and causative factors in perianal dermatitis: results of a prospective study in 126 patients (2006) (43)
Quantitative patch and repeated open application testing in methyldibromo glutaronitrile‐sensitive patients (2005) (43)
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies (2020) (42)
A silver man (2004) (42)
Schnitzler syndrome: response to anakinra in two cases and a review of the literature (2009) (40)
Asymptomatic Sensitization to Hymenoptera Venom Is Related to Total Immunoglobulin E Levels (2008) (40)
Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST‐2 open‐label study (2013) (40)
Skin testing for IgE-mediated drug allergy. (2009) (39)
Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria. (2016) (39)
Pigmented purpuric contact dermatitis from Disperse Blue 106 and 124 dyes. (2001) (38)
Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema. (2017) (38)
/ GA 2 LEN / EDF / WAO guideline for the definition , classification , diagnosis and management of urticaria (2018) (38)
Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics (2019) (37)
Contact allergy and medicinal herbs (2007) (37)
Skin cancer induced by natural UV‐radiation as an occupational disease – Requirements for its notification and recognition (2014) (37)
Twice‐daily versus Once‐daily Applications of Pimecrolimus Cream 1% for the Prevention of Disease Relapse in Pediatric Patients with Atopic Dermatitis (2009) (37)
Delayed‐type hypersensitivity to low molecular weight heparins and heparinoids: cross‐reactivity does not depend on molecular weight (2007) (35)
Histiocytosis X cells in eosinophilic granuloma express Ia and T6 antigens. (1983) (35)
Efficacy of cetirizine in cholinergic urticaria. (1995) (35)
Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer (1997) (33)
Olive oil – contact sensitizer or irritant? (1997) (33)
Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals (2015) (33)
For the European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity. General considerations on rapid desensitization for drug hypersenitivity - a consensus statement (2010) (33)
Negative venom skin test results and mastocytosis. (2004) (33)
The new EURO releases nickel and elicits contact eczema (2002) (33)
Natural and recombinant enzymatically active or inactive bee venom phospholipase A2 has the same potency to release histamine from basophils in patients with Hymenoptera allergy. (1995) (33)
Immunological differences between insect venom‐allergic patients with and without immunotherapy and asymptomatically sensitized subjects (2018) (32)
[Benzalkonium chloride--a relevant contact allergen or irritant? Results of a multicenter study of the German Contact Allergy Group]. (1993) (31)
Should patch testing be restricted to dermatologists only? (1993) (31)
Acute generalized exanthematous pustulosis from dalteparin. (2007) (30)
IgG antibodies typical for extrinsic allergic alveolitis--an inter-laboratory quality assessment. (2001) (29)
Iodopropynylbutyl carbamate 0·2% is suggested for patch testing of patients with eczema possibly related to preservatives (2004) (29)
Simultaneous intradermal testing with hymenoptera venoms is safe and more efficient than sequential testing (2013) (29)
A novel dipstick developed for rapid Bet V 1‐specific IgE detection: recombinant allergen immobilized via a monoclonal antibody to crystalline bacterial cell‐surface layers (1998) (29)
European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis (2019) (28)
Accidental perforating bone injury using the EpiPen® autoinjection device (2005) (28)
Typing of Leukemic Cells with Monoclonal Antibodies. a (1983) (27)
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic (2020) (27)
Absence of contact sensitization to Aloe vera (L.) Burm. f. (2005) (27)
S2k‐Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion (2016) (27)
Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen. (2011) (26)
Analysis of the Antibody Responses Induced by Subcutaneous Injection Immunotherapy with Birch and Fagales Pollen Extracts Adsorbed onto Aluminum Hydroxide (2009) (26)
Cross-reacting allergens in tree pollen and pollen-related food allergy: implications for diagnosis of specific IgE. (1997) (26)
Prevalence of hymenoptera venom allergy and poor adherence to immunotherapy in Austria (2011) (25)
Adrenal Insufficiency as a Result of Long-Term Misuse of Topical Corticosteroids (2014) (24)
Morphological and phenotypical characterization of bone marrow-derived dendritic Thy-1-positive epidermal cells of the mouse. (1985) (24)
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey (2017) (24)
Drug eruptions from mesna. After cyclophosphamide treatment of patients with systemic lupus erythematosus and dermatomyositis. (1992) (24)
Contact dermatitis from Solvent Yellow 146 in a permanent marker (2001) (24)
Intradermal Tests With Drugs: An Approach to Standardization (2020) (24)
Determination of sIgE to rPhl p 1 is sufficient to diagnose grass pollen allergy (2013) (24)
Allergological approach to drug hypersensitivity reactions (2008) (24)
Questionable diagnostic benefit of the commercially available panel of bee venom components (2017) (23)
Oral xylose isomerase decreases breath hydrogen excretion and improves gastrointestinal symptoms in fructose malabsorption – a double‐blind, placebo‐controlled study (2012) (23)
Pitfalls in drug allergy skin testing: false–positive reactions due to (hidden) additives (2006) (23)
Clinical characteristics of patients with repeated systemic reactions during specific immunotherapy with hymenoptera venoms (1991) (23)
EAACI Position paper + : Adrenaline for emergency kits (1995) (22)
Thimerosal is a frequent sensitizer but is not in the standard series (1995) (22)
Diamine oxidase (DAO) serum activity : not a useful marker for diagnosis of histamine intolerance (2009) (22)
[The nephrotoxic effect of therapy with fumaric acid esters in psoriasis]. (2008) (22)
Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey (2018) (21)
[Atopic dermatitis: S2 guidelines]. (2009) (21)
Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy (2018) (21)
Reactions to formaldehyde and formaldehyde releasers in a standard series (1996) (21)
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA (2020) (21)
The Drug Ambassador Project - The diversity of diagnostic procedures for drug allergy around Europe (2005) (20)
CXCL13 and B‐cell activating factor as putative biomarkers in systemic sclerosis (2013) (20)
Human cowpox in a veterinary student. (2010) (20)
Helicobacter pylori in acquired cold urticaria (2001) (20)
A multicenter study ofsynchronous left- versus right-sided patch tests by the German Contact Dermatitis Research Group (1994) (20)
Seasonal influence on patch test results in Central Europe (1996) (20)
Accumulation of [3H]ATP in small dense core vesicles of superfused vasa deferentia (1979) (20)
Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence (2020) (20)
Sensitivity and specificity of Hymenoptera allergen components depend on the diagnostic assay employed. (2016) (19)
Subacute lupus erythematosus during treatment with golimumab for seronegative rheumatoid arthritis (2014) (19)
[Post-zoster-specific skin infiltrates in chronic lymphatic leukemia]. (1990) (19)
Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy. (2007) (19)
Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey. (2015) (19)
[Sensitization to tea tree oil in Germany and Austria. A multicenter study of the German Contact Dermatitis Group]. (2003) (18)
In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells. (1986) (18)
The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries (2017) (18)
Reduction of side effects of specific immunotherapy by premedication with antihistaminics and reduction of maximal dosage to 50.000 SQ-U/ml. (1988) (18)
Particle segregation in chromaffin granule membranes by forced physical contact. (1978) (18)
Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis (2021) (18)
Cutaneous reactions to GM-CSF in inflammatory breast cancer. (1992) (17)
Hymenoptera stings in the head region induce impressive, but not severe sting reactions (2016) (17)
Anaphylaxis after a Mongolian gerbil bite (2004) (17)
Tryptase as Severity Marker in Drug Provocation Tests (2006) (17)
Herpetic folliculitis and syringitis simulating acne excoriée. (2001) (17)
IgE antibodies to penicillin are indicative for but not conclusive proof of penicillin allergy (2006) (17)
Allergic Reaction to Pigments and Metals (2009) (17)
Moving Toward Optimizing Testing for Penicillin Allergy. (2017) (16)
Chromated metal products may be hazardous to patients with chromate allergy (2009) (16)
Homoeopathic preparations--severe adverse effects, unproven benefits. (1991) (16)
[Patch testing with the "Austrian standard series"--epidemiologic test values and results]. (1995) (16)
MI (2-methyl-4-isothiazolin-3-one) contained in detergents is not detectable in machine washed textiles (2018) (16)
Efficacy of octenidine dihydrochloride and 2-phenoxyethanol in the topical treatment of inflammatory acne. (2008) (16)
Contact allergy to Euxyl K 400 : results of a multi-center study of the German Contact Allergy Group (DKG) (1991) (16)
Hymenoptera Venom Allergy: Time Course of Specific IgE Concentrations during the First Weeks after a Sting (1999) (16)
Disease spectrum in patients with elevated serum tryptase levels (2015) (16)
Macrolide-induced Churg-Strauss syndrome in patient with atopy (1997) (15)
International Comparison of Legal Aspects of Workers’ Compensation for Occupational Contact Dermatitis (2011) (15)
Monoclonal antibody to a 43 000 Mr surface protein of a human leukaemia cell line (THP-1) crossreacts with the fibroblast intermediate filament protein vimentin. (1985) (15)
Methotrexate Treatment for Pityriasis Rubra Pilaris: A Case Series and Literature Review. (2018) (15)
Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Commentary. (2007) (15)
Contact urticaria from roe deer meat and hair (1998) (15)
A double-blind study of loratadine and cetirizine in atopic dermatitis (1997) (14)
[Scleromyxedema: immunosuppressive therapy with cyclophosphamide]. (1988) (14)
Updated evidence‐based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy (2017) (14)
Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice (2017) (14)
Bufexamac is a frequent contact sensitizer (1996) (13)
Treatment of livedoid vasculopathy with alprostadil (PGE‐1): case report and review of published literature (2013) (13)
Delayed-type skin reaction to the heparin-alternative danaparoid. (2000) (13)
[Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon-beta injection]. (1998) (13)
Near‐fatal anaphylaxis caused by human serum albumin in fibrinogen and erythrocyte concentrates (2014) (13)
Platitudes in allergy – based on the example of the euro (2001) (13)
β‐blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy (2021) (13)
[Anal and palmar contact dermatitis caused by iodopropynyl butylcarbamate in moist sanitary wipes]. (2003) (12)
Active sensitization to elecampane by patch testing with a crude plant extract (1990) (12)
Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey (2017) (12)
[Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides]. (1982) (12)
Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey (2017) (12)
Measurement of IgE antibodies using liquid allergens--an inter-method and inter-laboratory quality assessment. (2002) (12)
Sulfasalazine-induced extrinsic allergic alveolitis in a patient with psoriatic arthritis. (2001) (12)
Food-induced anaphylaxis and cofactors – data from the anaphylaxis registry (2017) (12)
Pinta in Austria (or Cuba?): import of an extinct disease? (1999) (11)
Hereditary angioedema treatment options: The availability of new therapies (2012) (11)
Assessment of specific immunotherapy efficacy using a novel placebo score-based method. (2012) (11)
Topical mercury should be banned--dangerous, outmoded, but still popular. (1991) (11)
[Allergic rhinitis and its impact on asthma (ARIA update 2008). The Austrian perspective]. (2009) (11)
[Epidemiologic data for tetanus prophylaxis. Assessment of the need for vaccination]. (1999) (11)
Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (10)
Face dermatitis from contaminants on a mask for anaesthesia (2000) (10)
Hereditary angioedema in Austria: prevalence and regional peculiarities (2019) (10)
Ammoniated mercury ointment: outdated but still in use (1990) (10)
Patch testing of nickel sulfate and potassium dichromate with a standardized ready-to-use test system gives highly reproducible results: a double-blind multicentre study. (2001) (9)
Progressive circumscribed sclerosis – a novel side‐effect of immunotherapy with aluminium‐adsorbed allergen extracts (2009) (9)
Angioedema is not just ‘deep urticaria’ but an entity of its own (2014) (9)
Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey (2019) (9)
Inhibition of cross-reactive carbohydrate determinants (CCDs) enhances the accuracy of in vitro allergy diagnosis (2017) (9)
Haploinsufficiency due to deletion within the 3′-UTR of C1-INH-gene associated with hereditary angioedema (2006) (9)
IgE multiplex testing in house dust mite allergy is utile, and sensitivity is comparable to extract‐based singleplex testing (2020) (9)
Laktam Antibiyotiklere Geç Reaksiyonların Tanısı DIAGNOSIS OF NONIMMEDIATE REACTIONS TO β-LACTAM ANTIBIOTICS (2008) (9)
In vitro allergy testing needs better standardization--test results from different laboratories lack comparability mostly due to missing effective standards. (1995) (8)
Effects of short-wave UV and PUVA treatment on structure and phenotype of bone marrow-derived dendritic cells of the mouse epidermis. (1986) (8)
[Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]. (2020) (8)
Allergy to colophony acquired backstage (1987) (8)
Cooperation between the occupational health insurance and physicians practicing occupational dermatology: Optimization potential in quality assurance (2014) (8)
[Epidemiologic surveillance of contact allergens. The "monitoring series" of IVDK (Information Network ofDermatologic Clinics for Detection and Scientific Evaluation of Contact Allergy]. (2003) (8)
The Importance of Including Thimerosal, an Increasingly Frequent Allergen in Europe, in Standard Screening Series for Allergic Contact Dermatitis (1991) (8)
An 8-year experience in airborne contact dermatitis (2004) (8)
Abstracts from the 10th C1-inhibitor deficiency workshop (2017) (8)
Iconographies supplémentaires de l'article : Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG 4 antibodies (2011) (8)
Adrenaline for emergency kits. (1995) (8)
Hereditary angioedema in children and adolescents – A consensus update on therapeutic strategies for German‐speaking countries (2020) (8)
[Correlation between chronic urticaria and depression/somatization disorder]. (1996) (8)
Occupational dermatitis from organically grown parsnip (Pastinaca sativa L.) (1992) (8)
The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks (2015) (7)
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GA 2 LEN platform. The (2009) (7)
Diagnosis and therapy of bee and wasp venom allergy (2012) (7)
Indoor exposure to formaldehyde and risk of allergy (2000) (7)
Pitfalls in patch testing: problems with rather than from Kathon CG (1990) (7)
β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy (2020) (7)
Possible utility of basophil activation test in dual honeybee and vespid sensitization. (2019) (7)
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper (2021) (7)
[T- and B-cell double lymphoma: immunologic characterization using monoclonal antibodies]. (1988) (7)
Contact irritation provoking Hailey‐Hailey disease (2001) (7)
Local anaesthesia with ethyl chloride freezing: problems despite proper application (1991) (7)
Hereditary angioedema and normal C1-inhibitor activity in women (2000) (7)
S2k-Leitlinie Neurodermitis (atopisches Ekzem, atopische Dermatitis) – Kurzversion (2016) (7)
Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing☆ (2019) (7)
Specificity of conventional and Ves v 5-spiked venom decreases with increasing total IgE. (2014) (6)
Ammonium thiolactate and thiolactic acid: important hairdressers' allergens? (2002) (6)
Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema (2021) (6)
Sclerodermiform porphyria cutanea tarda after torasemide (2015) (6)
Drug hypersensitivities: the need for standardization. (2005) (6)
Position paper Diagnosis of immediate allergic reactions to beta-lactam antibiotics (2003) (6)
Modulation of antigen presenting cell function by in vivo administration of anti ia antibodies (1985) (6)
Positive nickel patch tests do not intensify positive reactions to adjacent patch tests with dichromate (2000) (6)
Bacitracin for lubrication: an allergen for more convenience? (2005) (6)
Clinical manifestations and mechanisms of skin reactions after systemic drug administration (2008) (6)
Pitfalls of patch testing with dental materials (2012) (6)
Successful allogeneic cord blood transplantation in a patient with Evans syndrome leads to correction of hereditary angioedema type I as secondary effect (2012) (6)
Extravascular Necrotizing Granuloma Induced by Mineral Wool in Circumscribed Scleroderma Lesions (2003) (5)
Fixed drug eruption on the penis due to oxcarbazepine. (2011) (5)
Comparability and quality of IgE-based in vitro allergy diagnosis: 25 years of external quality assessment (2014) (5)
Triggers and Treatment of Anaphylaxis (2018) (5)
Masked penicillin exposure leading to intensive care unit treatment (2005) (5)
Erysipelas of the Thigh and the Gluteal Region: Retrospective Multicenter Analysis of a Very Rare Entity in 39 Patients (2012) (5)
A safe and efficient 7‐week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom (2019) (5)
[Contact eczema and epicutaneous tests--distribution of allergens and changes in the spectrum in Vienna]. (1991) (5)
Multicentre studies and conflicting prevalence data (1992) (5)
Anaphylaxis with clonal mast cells in normal looking skin – a new entity? (2015) (5)
Allergy Alert Test for p-Phenylenediamine-Allergic Hair Dye Users. (2018) (5)
Clinical relevance of + patch test reactions to lanolin alcohol (2002) (5)
Surgical management of extensive gnathophyma (2006) (5)
Correction: Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment (2013) (4)
Clinical effectiveness of hymenoptera venom immunotherapy (2013) (4)
Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings. (2019) (4)
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2017) (4)
Oral Plasma Kallikrein Inhibitor BCX7353 is Safe and Effective as an On‐Demand Treatment of Angioedema Attacks in Hereditary Angioedema (HAE) Patients: Results of the ZENITH‐1 Trial: 110 (2019) (4)
Allergic Reactions to Pigments, Metals, and More? Body Art from the Allergist’s Point of View (2018) (4)
Cocospropylenediamine‐guanidinium diacetate: synonyms and cross‐reactants (2002) (4)
Desloratadine for the Relief of Nasal and Non-nasal Allergy Symptoms: An Observational Study (2009) (4)
Penicillin Allergy: Mono-, Double-, and Multiple-Drug Hypersensitivity, or Even No Sensitivity? (2017) (4)
Effect of UVB radiation on the biosynthesis of HLA-DR antigens (2004) (3)
IgE response to penicillin (1997) (3)
Evaluation of a Self-Test Device Used in Allergic Contact Dermatitis (2015) (3)
Multiple glomus tumors of the skin with male-to-male transmission over four generations. (2001) (3)
Acne excoriata – Look for Allergy! (2001) (3)
Corticosteroid contact dermatitis : Results of a multicenter study from the German Contact Allergy Group (1997) (3)
OLIVE OIL: CONTACT SENSITIZER OR IRRITANT? AUTHORS' REPLY (1997) (3)
One‐year treatment of chronic urticaria with mizolastine: efficacy and safety. J Eur Acad Dermatol Venereol 2000; 14: 83–90 (2001) (3)
[Mucosal diseases from an allergological perspective]. (2016) (3)
Bees and Wasps May Be Dangerous, but Who Is at Risk? (2010) (3)
Toxocarosis and putative DRESS syndrome in an oncological patient: a case report (2014) (3)
[Immunofluorescence studies of the human trabecular meshwork]. (1983) (3)
Correction to: Guideline for the diagnosis of drug hypersensitivity reactions (2018) (3)
[Amalgam allergy--diagnosis and consequences]. (1996) (2)
Allergen immunotherapy in the current COVID-19 pandemic - A position paper of the AeDA, ARIA, EAACI, DGAKI and GPA (2020) (2)
The crux of C1-INH testing in everyday lab work. (2021) (2)
Potential drug‐drug interactions and adverse drug reactions in dermatological inpatients (2016) (2)
Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (2016) (2)
[Immunological investigation in primary open angle glaucoma (author's transl)]. (1982) (2)
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study (2018) (2)
Gold Is Precious-But a Potent Sensitizer? (2019) (2)
Effects of in vivo administration of anti-Ia antibodies on contact sensitivity. (1989) (2)
Guideline on Lichen sclerosus (2014) (2)
Recurrent Herpes Simplex Infection in Multiple Locations in an Otherwise Healthy Boy (2010) (2)
Variability of disease activity in patients with hereditary angioedema type 1/2: longitudinal data from the Icatibant Outcome Survey (2021) (2)
A position paper on drug allergy – pinpointing problems rather than suggesting solutions (2016) (2)
[Chrysanthemum allergy]. (1987) (2)
Response to Letter by Prof. C.B.B. Bunker (2017) (2)
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study (2018) (2)
Vascular pattern of the palms – a clinical feature of atopic skin diathesis (2006) (2)
Diagnosis and Treatment of Melanoma. European Consensus ⴀbased Interdisciplinary Guideline Developed by the Guideline Subcommittee of the (2012) (2)
[Allergic contact dermatitis of the scalp]. (2017) (2)
Contact Dermatitis (2007) (1)
Occupational contact dermatitis caused by isopropanol‐containing disinfectant based on a genetic defect (2018) (1)
Dermatomyositis/polymyositis and anti-TNF-α therapies: a literature review (2013) (1)
Diagnosing Cefazolin Hypersensitivity: Important Steps Forward, but We Haven't Reached the Goal Yet. (2016) (1)
IHAE-Qol: Specific Health-Related Quality Of Life (HRQoL) Questionnaire In Hereditary Angioedema Due To C1 Inhibitor Deficiency (HAE-C1INH) (2014) (1)
Hereditary Angioedema - an orphan but an original disease? (2021) (1)
Desloratadine for the Relief of Nasal and Non-Nasal Allergic Symptoms: an Observational Study (2006) (1)
Medical Photography: Documentation, Art, and the Expression of Human Emotions (2016) (1)
Icatibant Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema: Findings from the Icatibant Outcome Survey: 127 (2019) (1)
Macro‐video documentation patch tests (2005) (1)
Chemical Substances and Contact Allergy‐244 Substances Ranked According to Allergenic Potency (2004) (1)
[Allergy to topical antihistamines--discrepancy between the literature and clinical practice]. (1988) (1)
Venom immunotherapy: pitfalls and open questions. (2011) (1)
The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema (2022) (1)
[Clinical practise guideline of the special interest group in allergy of the ÖGDV - Drug provocation testing in the diagnosis of cutaneous drug reactions]. (2011) (1)
[Guidelines of the Germany Dermatological Society (DDG) for the management of contact allergies with skin tests]. (2001) (1)
1st Science Days of the Austrian Society of Dermatology and Venereology (ÖGDV Forschungstage). (2016) (1)
Allergological diagnostics of hypersensitivity reactions to drugs (2008) (1)
Occupational allergic contact urticaria to tropomyosin from squid (2020) (1)
[Epidemiology and diagnosis of allergic diseases]. (1993) (1)
Reply: LETTER TO THE EDITOR (2002) (1)
History of Misdiagnosis in Patients with Hereditary Angioedema Participating in the Icatibant Outcome Survey (2015) (1)
[Food allergies and intolerance--epidemiologic studies]. (1996) (1)
Erratum to: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement (2017) (1)
Early Versus Late Administration of Icatibant in Patients With Hereditary Angioedema (2017) (1)
[Rochus, patron saint of physicians and hospitals--a teledermatologic quiz]. (2006) (1)
Molecular allergy diagnosis is sensitive and avoids misdiagnosis in patients sensitized to seasonal allergens (2023) (1)
[Contact eczema and "standard test"--do "International Standard Test Series" coincide with Austrian local characteristics?]. (1991) (1)
Pet-fish food lung- a new form of extrinsic allergic alveolitis. (2000) (1)
[Immunopathogenesis of primary open-angle glaucoma]. (1982) (1)
The Icatibant Outcome Survey: Rate and Impact Of Treatment By Self-Administration (2014) (0)
Import of an Extinct Disease (2015) (0)
[How dangerous is amalgam?]. (1998) (0)
Biomarkers in Insect Venom Allergy - The Key to All Diagnostic Problems? (2021) (0)
Tolerability and Cross-reactivity of 3 New Hair Colorants in p-Phenylenediamine-Allergic Individuals. (2022) (0)
Sensitization to Kathon CG in Austria: low sensitization rate, no clinical relevance, and controversial literature data (1990) (0)
Body Art from the Allergist's Point of View (2010) (0)
[The spectrum of Lyme borreliosis from the dermatologic viewpoint]. (1988) (0)
Evaluation of Allergologic Tests in Exanthematous Drug Eruptions after Application of Mesna (2003) (0)
Characterization Of Hereditary Angioedema Attacks Requiring Reinjection Of Icatibant: Findings From The Icatibant Outcome Survey (2018) (0)
ILDS Newsletter No. 27 (2013) (0)
375 Side effects of specific immunotherapy, reduction by pretreatment with antihistamins (1988) (0)
[Meeting report on the "2nd Dermatologic Alps Seminar" Allergology, Occupational and Environmental Dermatology 25 to 28 May 1995 in Berchtesgaden]. (1996) (0)
Conflicts of interests 2 The Work Under Consideration for Publication (2014) (0)
Therapy of urticaria: German language version of the international S3-guideline (2012) (0)
Health-Related Quality Of Life (HRQoL) In Adult Patients With Hereditary Angioedema Due To C1 Inhibitor Deficiency (HAE-C1-INH) Assessed By SF-36v2 (2014) (0)
The Icatibant Outcome Survey: Characterizing Breakthrough Hereditary Angioedema Attacks In Patients Receiving Long-Term Prophylaxis (2014) (0)
University of Southern Denmark Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema Aygören-Pürsün, (2018) (0)
P164 Longitudinal natural history of patients with type I/II hereditary angioedema: icatibant outcome survey data (2017) (0)
FS05.5 The European Standard Series in 8 European countries – first results of the ESSCA network (2004) (0)
[Quality control in the allergy laboratory--4 years "Allergy Ring Trial" in Austria]. (1992) (0)
Reply (2002) (0)
UvA-DARE ( Digital Academic Repository ) Reducing the Risk of Anaphylaxis During Anesthesia : 2011 Updated Guidelines for Clinical Practice (2011) (0)
Statin Allergy: An Evidence-Based Approach. (2015) (0)
PSY6 THE ICATIBANT OUTCOME SURVEY:A PROSPECTIVE STUDY OF SAFETY AND EFFECTIVENESS OF ICATIBANT IN A ‘REAL WORLD' SETTING IN PATIENTS WITH HEREDITARY ANGIOEDEMA (2010) (0)
Reply (1997) (0)
Heparin Allergy: Frequently Suspected, Seldom Proven, and Easily Circumvented. (2022) (0)
ProvocationTests in Drug Hypersensitivity (2009) (0)
Langerhans Cells in Contact Hypersensitivity (1981) (0)
Exanthema with eosinopenia (2002) (0)
Benefits of Early Administration with Icatibant for the Treatment of Hereditary Angioedema Attacks (2013) (0)
Strong Dose‐response Using a Conjunctival Provocation Test During a Phase II Allergen Immunotherapy Study With Subcutaneously Administered Tyrosine Adsorbed Modified Grass Allergen + MPL: 866 (2019) (0)
Localized hyperhidrosis in the distal right arm (2014) (0)
The Icatibant Outcome Survey: More Than 1500 Icatibant-Treated Attacks in Patients with Type I or II Hereditary Angioedema (2015) (0)
Update of the Guideline on Chronic Urticaria (2014) (0)
Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQwl and DQw3 alleles of the HLA-D region (HLA-disease associations/autoimmunity) (2016) (0)
The Icatibant Outcome Survey: Observational Data in Patients with Angioedema Due to Acquired C1 Inhibitor (C1-INH) Deficiency (2015) (0)
Contents Vol. 228, 2014 (2014) (0)
Safety and Convenience of Self-Administered Icatibant for the Treatment of Acute Hereditary Angioedema Attacks (2013) (0)
Differential Effects of Various Physicochemical Agents on Murine Ia- and Thy-1 Positive Dendritic Epidermal Cells (1988) (0)
Familial leiomyomatosis Author : Dr (2004) (0)
[Induction of penicillin tolerance during pregnancy : Allergological opinion on the recommendation of the current Guidelines on Diagnosis and Treatment of Syphilis (AWMF Registry No. 059-002)]. (2021) (0)
University of Southern Denmark Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice Zanichelli, (2017) (0)
"Despite all the new developments in the diagnosis of insect venom allergies, there still remain many unmet needs in the diagnosis and treatment of insect sting hypersensitivity ." (2011) (0)
Acknowledgement to the Reviewers (2018) (0)
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis (2023) (0)
Reply (1996) (0)
The Allergy Alert Test: Introduction of a Protocol Suitable to Provide an Alert Signal in p-Phenylenediamine-Allergic Hair Dye Users. (2018) (0)
The Icatibant Outcome Survey: Characteristics Of Patients With Hereditary Angioedema Requiring Reinjection (2014) (0)
Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) (2021) (0)
Guideline on Lichen sclerosus Developed by the Guideline (2014) (0)
["The standard epicutaneous test"]. (1989) (0)
The Drug Ambassador ProjectDiversity of Diagnostic Procedures for (2005) (0)
Induction of penicillin tolerance during pregnancy: Allergological opinion on the recommendation of the current AWMF Guidelines on Diagnosis and Treatment of Syphilis (AWMF Registry No. 059-002) (2021) (0)
O006 Open-label, non-randomized study of single-dose icatibant in pediatric patients with hereditary angioedema: Primary/secondary/pharmacokinetic analyses (2016) (0)
Use of biologics in allergic and type 2 inflammatory diseases in the current Covid 19 pandemic(a, b, c) (2020) (0)
[Professor Brunello Wüthrich -- the 65th birthday]. (2003) (0)
Selection of the optimal dose for an ultra-short course subcutaneous immunotherapy (SCIT) for Rhinoconjunctivitis for Birch Allergic patients (2017) (0)
Author response for "Hereditary angioedema in children and adolescents – A consensus update on therapeutic strategies for German‐speaking countries" (2020) (0)
Keto rash following carbohydrate restriction (2022) (0)
Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema (2021) (0)
Dermatitis, nonmelanoma skin cancer and leg ulcers (2016) (0)
P5.095 Cefixime Treatment Failure in Infections with Cefixime Susceptible N. Gonorrhoea Strains (2013) (0)
CHILD syndrome Author : (2004) (0)
Strong Dose‐response On Immunoglobulin Makers During a Phase II Allergen Immunotherapy Study With Subcutaneously Administered Tyrosine Adsorbed Modified Grass Allergen + MPL: 927 (2019) (0)
Gender Analysis of Icatibant-Treatment Outcomes of Acute Angioedema Attacks in Patients with Hereditary Angioedema Type I and II: Results from the Icatibant Outcome Survey (2016) (0)
O005 Improvement in hereditary angioedema diagnosis: Findings from the icatibant outcome survey (2016) (0)
[Relevance of a positive test reaction to merthiolate]. (1990) (0)
Erythema migrans mimicking early morphea (2020) (0)
Biologics and immunotherapy Safety and efﬁcacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32 (2019) (0)
O004 Childhood presenting hereditary angioedema is diagnosed in adulthood by non-pediatric physicians: Icatibant outcome survey findings (2016) (0)
[The "false-positive" patch test reaction]. (1988) (0)
Prevalence of HIV-1 antibodies in specimens of a Safe' laboratory (1993) (0)
[Edematous papules and papulovesicles in mother and child. Asymmetric arrangement on the thorax and linear on the extremities]. (2004) (0)
CMR 2005: 11.06: European multicenter study on contrast media hypersensitivity (2006) (0)
Early treatment with icatibant significantly reduces duration and time to resolution of hereditary angioedema attacks: 129 (2013) (0)
[Not Available]. (2016) (0)
Correction. (2020) (0)
Contents, Vol. 182, 1991 (1991) (0)
The Icatibant Outcome Survey: Trigger Factors and Premonitory Symptoms of Angioedema Attacks in Patients with Hereditary Angioedema (2015) (0)
FS04.5 Iodopropynylbutyl carbamate (IPBC) 0.2% is suggested for patch testing of patients with eczema possibly related to preservatives (2004) (0)
[Atopic dermatitis. Version (17 July 2002 - modified final version)]. (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Werner Aberer?

Werner Aberer is affiliated with the following schools:

Werner Aberer's Academic­Influence.com Rankings